Shopping Cart

Remove All
Your shopping cart is currently empty

Cyanosafracin B

Name: Cyanosafracin B
Brand: TargetMol
SKU: T22286
Price: 37 USD
Availability: InStock
Rating: 5 (10 reviews)

🥰Excellent

Catalog No. T22286Cas No. 96996-50-8

Alias Cyanoquinonamine, CBR28-1

Cyanosafracin B is a starting material for the synthesis of Phthalascidin Pt-650 and Ecteinascidin ET-743.

$Cyanosafracin B$

Cyanosafracin B

🥰Excellent

Purity: 99.6%

Catalog No. T22286Alias Cyanoquinonamine, CBR28-1Cas No. 96996-50-8

Cyanosafracin B is a starting material for the synthesis of Phthalascidin Pt-650 and Ecteinascidin ET-743.

Pack Size	Price	Availability
2 mg	$37	In Stock
5 mg	$62	In Stock
10 mg	$98	In Stock
25 mg	$193	In Stock
50 mg	$280	In Stock
100 mg	$392	In Stock
200 mg	$527	In Stock
1 mL x 10 mM (in DMSO)	$71	In Stock

Add to Cart

Add to Quotation

Bulk & Custom

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.6%

Resource Download

COA HNMR LCMS

Product Introduction

Bioactivity

Description	Cyanosafracin B is a starting material for the synthesis of Phthalascidin Pt-650 and Ecteinascidin ET-743.
Synonyms	Cyanoquinonamine, CBR28-1

Chemical Properties

Molecular Weight	549.62
Formula	C₂₉H₃₅N₅O₆
Cas No.	96996-50-8
Smiles	[H][C@@]12Cc3cc(C)c(OC)c(O)c3[C@@]([H])(N1C)[C@]1([H])CC3=C([C@H](CNC(=O)[C@H](C)N)N1[C@H]2C#N)C(=O)C(OC)=C(C)C3=O
Relative Density.	1.39 g/cm3 (Predicted)

Storage & Solubility Information

Storage

store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 55 mg/mL (100.07 mM), Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	1.8194 mL	9.0972 mL	18.1944 mL	90.9719 mL
5 mM	0.3639 mL	1.8194 mL	3.6389 mL	18.1944 mL
10 mM	0.1819 mL	0.9097 mL	1.8194 mL	9.0972 mL
20 mM	0.0910 mL	0.4549 mL	0.9097 mL	4.5486 mL
50 mM	0.0364 mL	0.1819 mL	0.3639 mL	1.8194 mL
100 mM	0.0182 mL	0.0910 mL	0.1819 mL	0.9097 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH₂O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH₂O TargetMol | reagent

mix well and clarify

For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.

All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

InhibitorinhibitCyanosafracin B